Provectus Pharmaceuticals, Inc. Stock OTC Bulletin Board
Equities
PVCT
US74373F1003
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 0.99 1.35 | Sales 2023 | 0.56 0.76 | Capitalization | 40.27M 55.06M |
---|---|---|---|---|---|
Net income 2022 | -3M -4.1M | Net income 2023 | -3M -4.1M | EV / Sales 2022 | 48,121,944 x |
Net Debt 2022 | 2.16M 2.96M | Net Debt 2023 | 2.95M 4.03M | EV / Sales 2023 | 77,502,175 x |
P/E ratio 2022 |
-12.8
x | P/E ratio 2023 |
-13
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.58% |
Managers | Title | Age | Since |
---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 71 | 18-04-26 |
Eric Wachter
FOU | Founder | 61 | 01-12-31 |
Heather Raines
DFI | Director of Finance/CFO | 58 | 17-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Wachter
FOU | Founder | 61 | 01-12-31 |
John Lacey
BRD | Director/Board Member | 76 | 18-04-26 |
President | 55 | 17-04-02 |
1st Jan change | Capi. | |
---|---|---|
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-2.33% | 21.28B | |
-5.15% | 18.8B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B |
- Stock Market
- Equities
- PVCT Stock
- PVCT Stock